CV
CVSA
Covista Inc.
$126.08
-0.20%
$4.3B
No data for this timeframe.
Vol
Market Cap$4.3B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (90%)
Inst. Holders10 funds
Inst. Value$953.3M
Inst. Activity2 buys / 3 sells
Insider Activity3B / 4S
Insider Net $-$2.6M
SEC Reports3
Recent Activity
May 18, 2026
Insider
Gangadharan Manjunath sold 426 shares
VP, Chief Accounting Officer @ $127.85 ($54.5K)
May 12, 2026
SEC
Four top executives at Covista (CVSA) sold a total of $4.82M in shares on May 8, 2026, one day after the company reporte
CLUSTER — Impact 4/10
May 11, 2026
short_interest
FTD: CVSA — 29,432 shares ($3.9M) failed to deliver
Settlement: 20260511, Price: $133.73, FTD Value: $3,935,941.36, COVISTA INC
May 8, 2026
Insider
Cox Karen Sue sold 2,000 shares
President, Chamberlain Univ. @ $124.50 ($249.0K)
May 8, 2026
Insider
Beard, Stephen W. sold 15,874 shares
Chairman & CEO @ $131.25 ($2.1M)
Apr 9, 2026
SEC
Covista Inc. released an investor newsletter highlighting its strategic focus on rural healthcare, the introduction of i
8-K — Impact 6/10
Feb 24, 2026
SEC
Covista Inc. hosted an investor day outlining its 'Purpose at Scale' growth strategy for FY27-FY29, reaffirming its FY26
8-K — Impact 7/10
Inst.
ARIEL INVESTMENTS, LLC — ADD
1,897,628 shares ($196.3M)
Price Targets
$156.25
+23.9% upside
Strong Buy
Current $126.08
Low $140.00
Median $155.00
High $175.00
4 analysts
$140.00
$175.00
Analyst Ratings
4Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 8, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
| May 11, 2026 | Truist Securities | MAINTAIN | Buy → Buy |
| Apr 17, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
| Mar 24, 2026 | Truist Securities | INITIATE | Buy |
| Mar 2, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.89 ▼ -1.9% | $1.83 — $1.93 | 14% YoY | 4 |
| Next Q | $1.79 ▼ -1.1% | $1.78 — $1.80 | 2% YoY | 2 |
| Current FY | $8.05 ▲ +1.9% | $8.00 — $8.09 | 21% YoY | 4 |
| Next FY | $8.89 ▲ +1.5% | $8.67 — $9.10 | 10% YoY | 4 |
Latest Reports
NEUTRAL
CLUSTER
4/10
Four top executives at Covista (CVSA) sold a total of $4.82M in shares on May 8, 2026, one day after the company reporte
May 12, 2026
BULLISH
8-K
6/10
Covista Inc. released an investor newsletter highlighting its strategic focus on rural healthcare, the introduction of i
Apr 9, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $450.0M | — |
| ARIEL INVESTMENTS, LLC | $196.3M | ADD |
| FMR LLC | $143.7M | ADD |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $50.0M | NEW |
| MORGAN STANLEY | $47.4M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 18, 2026 | Gangadharan Manjunath | F | $54.5K |
| May 8, 2026 | Cox Karen | SELL | $249.0K |
| May 8, 2026 | Beard, Stephen | SELL | $2.1M |
| May 8, 2026 | BECK DOUGLAS | SELL | $1.2M |
| May 8, 2026 | Phelan Robert | SELL | $1.3M |
10 institutional holders with $953.3M total value (9,213,749 shares) as of 2025-Q4. Top holders: VANGUARD, ARIEL, FMR. Net selling activity: 3 institutions trimmed/exited vs 2 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 4,348,951 | $450.0M | 47.2% | — |
| 2 | ARIEL INVESTMENTS, LLC | 1,897,628 | $196.3M | 20.6% | ADD +46.5% |
| 3 | FMR LLC | 1,389,240 | $143.7M | 15.1% | ADD +32.5% |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 482,868 | $50.0M | 5.2% | NEW |
| 5 | MORGAN STANLEY | 457,746 | $47.4M | 5.0% | — |
| 6 | TWO SIGMA INVESTMENTS, LP | 347,582 | $36.0M | 3.8% | ADD +57.4% |
| 7 | BANK OF AMERICA CORP /DE/ | 147,193 | $15.2M | 1.6% | TRIM -37.7% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 61,700 | $6.4M | 0.7% | TRIM -45.8% |
| 9 | WELLS FARGO & COMPANY/MN | 52,829 | $5.5M | 0.6% | TRIM -33.6% |
| 10 | NORGES BANK | 28,012 | $2.9M | 0.3% | NEW |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| ARIEL INVESTMENTS, LLC | ADD | 1,294,876 | 1,897,628 | +46.5% | $196.3M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 236,428 | 147,193 | -37.7% | $15.2M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 113,900 | 61,700 | -45.8% | $6.4M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | TRIM | 79,606 | 52,829 | -33.6% | $5.5M | 2025-Q4 |
| NORGES BANK | NEW | — | 28,012 | — | $2.9M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 182,784 | 287,753 | +57.4% | $44.4M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 179,400 | 113,900 | -36.5% | $17.6M | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | ADD | 59,478 | 79,606 | +33.8% | $12.3M | 2025-Q3 |
| NORGES BANK | EXIT | 29,476 | 0 | -100.0% | $0.00 | 2025-Q3 |
| ARIEL INVESTMENTS, LLC | TRIM | 1,856,878 | 1,375,687 | -25.9% | $175.0M | 2025-Q2 |
| FMR LLC | ADD | 939,211 | 1,244,682 | +32.5% | $158.4M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | ADD | 102,828 | 182,784 | +77.8% | $23.3M | 2025-Q2 |
| NORGES BANK | NEW | — | 29,476 | — | $3.8M | 2025-Q2 |
| FMR LLC | DOUBLED | 380,242 | 939,211 | +147.0% | $94.5M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 317,800 | 209,700 | -34.0% | $21.1M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 45,600 | 102,828 | +125.5% | $10.3M | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 136,625 | 53,285 | -61.0% | $5.4M | 2025-Q1 |
| NORGES BANK | EXIT | 122,802 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 45,300 | 136,625 | +201.6% | $12.4M | 2024-Q4 |
| UBS Group AG | DOUBLED | 40,895 | 101,610 | +148.5% | $9.2M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 590,019 | — | $44.5M | 2024-Q3 |
7 unique insiders with 7 transactions. Net insider value: -$2.6M ($2.2M bought, $4.8M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 18, 2026 | Gangadharan Manjunath | VP, Chief Accounting Officer | F | 426 | $127.85 | $54.5K |
| May 8, 2026 | Cox Karen Sue | President, Chamberlain Univ. | SELL | 2,000 | $124.50 | $249.0K |
| May 8, 2026 | Beard, Stephen W. | Chairman & CEO | SELL | 15,874 | $131.25 | $2.1M |
| May 8, 2026 | BECK DOUGLAS G. | SVP, GC, Corp. Sec & ISS | SELL | 9,615 | $127.03 | $1.2M |
| May 8, 2026 | Phelan Robert J. | Chief Financial Officer | SELL | 10,000 | $126.21 | $1.3M |
| Apr 15, 2026 | Liles Scott | President, Medical and Vet | F | 448 | $112.49 | $50.4K |
| Mar 11, 2026 | MALAFRONTE MICHAEL W | Director | BUY | 8,890 | $100.94 | $897.3K |
| Mar 10, 2026 | MALAFRONTE MICHAEL W | Director | BUY | 11,841 | $100.86 | $1.2M |
| Mar 3, 2026 | MALAFRONTE MICHAEL W | Director | BUY | 1,200 | $97.97 | $117.6K |
3 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 5.7/10.
NEUTRAL
CLUSTER
4/10
Four top executives at Covista (CVSA) sold a total of $4.82M in shares on May 8, 2026, one day after
May 12, 2026
BULLISH
8-K
6/10
Covista Inc. released an investor newsletter highlighting its strategic focus on rural healthcare, t
Apr 9, 2026
BULLISH
8-K
7/10
Covista Inc. hosted an investor day outlining its 'Purpose at Scale' growth strategy for FY27-FY29,
Feb 24, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (90% buy). Based on 10 analysts: 4 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$156.25 mean target
+23.9% upside
Strong Buy (1.25)
$140.00 Low
$175.00 High
| Metric | Value |
|---|---|
| Current Price | $126.08 |
| Target Low | $140.00 |
| Target Mean | $156.25 |
| Target Median | $155.00 |
| Target High | $175.00 |
| # Analysts | 4 |
| Recommendation | Strong Buy (1.25) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.89 | $1.83 | $1.93 | 14.0% | -1.9% | 0↑ 1↓ | $0.5B | 6.4% | 4 |
| Next Q 2026-09-30 |
$1.79 | $1.78 | $1.80 | 2.3% | -1.1% | 0↑ 1↓ | $0.5B | 6.3% | 2 |
| Current FY 2026-06-30 |
$8.05 | $8.00 | $8.09 | 20.8% | +1.9% | 1↑ 0↓ | $1.9B | 8.4% | 4 |
| Next FY 2027-06-30 |
$8.89 | $8.67 | $9.10 | 10.3% | +1.5% | 2↑ 0↓ | $2.1B | 6.7% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.893 | |
| 7d ago | $1.942 | -0.050 |
| 30d ago | $1.930 | -0.037 |
| 60d ago | $1.930 | -0.037 |
| 90d ago | $2.033 | -0.141 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 8, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| May 11, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Apr 17, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Mar 24, 2026 | Truist Securities | INITIATE | — | Buy |
| Mar 2, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Jan 29, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 5 | 1 | 0 | 0 | 90% | |
| May 1, 2026 | 4 | 5 | 1 | 0 | 0 | 90% | |
| Apr 1, 2026 | 4 | 5 | 1 | 0 | 0 | 90% | |
| Mar 1, 2026 | 4 | 4 | 1 | 0 | 0 | 89% | |
| Feb 1, 2026 | 5 | 4 | 1 | 0 | 0 | 90% | |
| Jan 1, 2026 | 5 | 4 | 1 | 0 | 0 | 90% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 11, 2026
short_interest
FTD: CVSA — 29,432 shares ($3.9M) failed to deliver
Settlement: 20260511, Price: $133.73, FTD Value: $3,935,941.36, COVISTA INC
May 7, 2026
earnings_calendar
CVSA Q3 2026 Earnings Scheduled — 2026-05-07
Mar 13, 2026
short_interest
FTD: CVSA — 5,254 shares ($0.5M) failed to deliver
Settlement: 20260313, Price: $103.84, FTD Value: $545,575.36, COVISTA INC
Mar 4, 2026
short_interest
FTD: CVSA — 9,070 shares ($0.9M) failed to deliver
Settlement: 20260304, Price: $102.70, FTD Value: $931,489, COVISTA INC